• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微粉化材料中粉末亚群存在的证据:雾化粉末的空气动力学粒径级分具有独特的物理化学性质。

Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.

作者信息

Jaffari Sara, Forbes Ben, Collins Elizabeth, Khoo Jiyi, Martin Gary P, Murnane Darragh

出版信息

Pharm Res. 2014 Dec;31(12):3251-64. doi: 10.1007/s11095-014-1414-3.

DOI:10.1007/s11095-014-1414-3
PMID:25015552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4224749/
Abstract

PURPOSE

To investigate the agglomeration behaviour of the fine (<5.0 μm) and coarse (>12.8 μm) particle fractions of salmeterol xinafoate (SX) and fluticasone propionate (FP) by isolating aerodynamic size fractions and characterising their physicochemical and re-dispersal properties.

METHODS

Aerodynamic fractionation was conducted using the Next Generation Impactor (NGI). Re-crystallized control particles, unfractionated and fractionated materials were characterized for particle size, morphology, crystallinity and surface energy. Re-dispersal of the particles was assessed using dry dispersion laser diffraction and NGI analysis.

RESULTS

Aerosolized SX and FP particles deposited in the NGI as agglomerates of consistent particle/agglomerate morphology. SX particles depositing on Stages 3 and 5 had higher total surface energy than unfractionated SX, with Stage 5 particles showing the greatest surface energy heterogeneity. FP fractions had comparable surface energy distributions and bulk crystallinity but differences in surface chemistry. SX fractions demonstrated higher bulk disorder than unfractionated and re-crystallized particles. Upon aerosolization, the fractions differed in their intrinsic emission and dispersion into a fine particle fraction (<5.0 μm).

CONCLUSIONS

Micronized powders consisted of sub-populations of particles displaying distinct physicochemical and powder dispersal properties compared to the unfractionated bulk material. This may have implications for the efficiency of inhaled drug delivery.

摘要

目的

通过分离空气动力学粒径级分并表征其物理化学和再分散特性,研究昔萘酸沙美特罗(SX)和丙酸氟替卡松(FP)的细颗粒(<5.0μm)和粗颗粒(>12.8μm)级分的团聚行为。

方法

使用下一代撞击器(NGI)进行空气动力学分级。对重结晶对照颗粒、未分级和分级后的材料进行粒径、形态、结晶度和表面能表征。使用干式分散激光衍射和NGI分析评估颗粒的再分散情况。

结果

雾化后的SX和FP颗粒以具有一致颗粒/团聚体形态的团聚体形式沉积在NGI中。沉积在第3级和第5级的SX颗粒比未分级的SX具有更高的总表面能,第5级颗粒表现出最大的表面能不均匀性。FP级分具有可比的表面能分布和整体结晶度,但表面化学存在差异。SX级分显示出比未分级和重结晶颗粒更高的整体无序度。雾化后,这些级分在其固有发射和分散成细颗粒级分(<5.0μm)方面存在差异。

结论

与未分级的块状材料相比,微粉化粉末由具有不同物理化学和粉末分散特性的颗粒亚群组成。这可能对吸入药物递送的效率有影响。

相似文献

1
Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.微粉化材料中粉末亚群存在的证据:雾化粉末的空气动力学粒径级分具有独特的物理化学性质。
Pharm Res. 2014 Dec;31(12):3251-64. doi: 10.1007/s11095-014-1414-3.
2
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.用于吸入丙酸氟替卡松和昔萘酸沙美特罗微晶的干粉制剂。
J Pharm Sci. 2009 Feb;98(2):503-15. doi: 10.1002/jps.21450.
3
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.丙酸氟替卡松与昔萘酸沙美特罗微晶定量吸入器的配方研究。
Pharm Res. 2008 Oct;25(10):2283-91. doi: 10.1007/s11095-008-9622-3. Epub 2008 May 29.
4
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.采用新型分级技术生产“空气动力学等效”药物和赋形剂吸入性粉末。
Eur J Pharm Biopharm. 2011 Feb;77(2):283-96. doi: 10.1016/j.ejpb.2010.11.021. Epub 2010 Dec 23.
5
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.丙酸氟替卡松与硫酸沙丁胺醇联合纳米颗粒聚集体作为干粉气雾剂。
Eur J Pharm Sci. 2011 Nov 20;44(4):522-33. doi: 10.1016/j.ejps.2011.09.014. Epub 2011 Sep 21.
6
Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.体外比较三种撞击器对复方干粉吸入剂制剂空气动力学沉积的影响
Int J Pharm. 2010 Mar 30;388(1-2):40-51. doi: 10.1016/j.ijpharm.2009.12.031. Epub 2009 Dec 21.
7
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.丙酸氟替卡松和沙美特罗联合干粉吸入剂(胶囊型和多剂量型)在哮喘和 COPD 患者中的药代动力学和药效学。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):279-89. doi: 10.1089/jamp.2013.1040. Epub 2013 Sep 28.
8
Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.高相对湿度储存后,吸入用粉雾剂中昔萘酸沙美特罗的聚集特性及分散性变化
Eur J Pharm Sci. 2009 Jun 28;37(3-4):442-50. doi: 10.1016/j.ejps.2009.03.016. Epub 2009 Apr 8.
9
Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment.含有昔萘酸沙美特罗和丙酸氟替卡松的复方颗粒:制剂与空气动力学评估。
J Pharm Sci. 2008 Jun;97(6):2299-310. doi: 10.1002/jps.21154.
10
Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).采用双极下一代撞击器(bp-NGI)测量商用 PMDI 悬浮液细颗粒气溶胶云的双极电荷分布。
Pharm Res. 2018 Nov 26;36(1):15. doi: 10.1007/s11095-018-2544-9.

引用本文的文献

1
Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations.质量源于设计在肺部药物传递中的应用:干粉吸入器开发、纳米治疗方法以及监管考虑因素的综述。
AAPS PharmSciTech. 2024 Aug 2;25(6):178. doi: 10.1208/s12249-024-02900-z.

本文引用的文献

1
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.使用干法分散激光衍射快速表征可吸入粉末的固有分散性。
Int J Pharm. 2013 Apr 15;447(1-2):124-31. doi: 10.1016/j.ijpharm.2013.02.034. Epub 2013 Feb 19.
2
Powder strength distributions for understanding de-agglomeration of lactose powders.了解乳糖粉末解团聚的粉末强度分布。
Pharm Res. 2012 Oct;29(10):2926-35. doi: 10.1007/s11095-012-0799-0. Epub 2012 Jun 14.
3
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
丙酸氟替卡松在干粉吸入剂制剂中的聚集行为。
Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.
4
Influence of solvent on the morphology and subsequent comminution of ibuprofen crystals by air jet milling.溶剂对空气喷射磨碎布洛芬晶体形态和后续粉碎的影响。
J Pharm Sci. 2012 Mar;101(3):1108-19. doi: 10.1002/jps.23003. Epub 2011 Dec 7.
5
Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.考察主结晶条件对丙酸氟替卡松载体干粉吸入剂配方的机械性能和二次加工行为的影响。
Pharm Res. 2012 Apr;29(4):994-1006. doi: 10.1007/s11095-011-0640-1. Epub 2011 Dec 9.
6
Surface energy analysis as a tool to probe the surface energy characteristics of micronized materials--a comparison with inverse gas chromatography.表面能分析作为一种探测微粉材料表面能特性的工具——与反气相色谱法的比较。
Int J Pharm. 2012 Jan 17;422(1-2):238-44. doi: 10.1016/j.ijpharm.2011.11.002. Epub 2011 Nov 10.
7
Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.结晶条件和给料形态对硫酸沙丁胺醇微粉气溶胶化性能的影响。
Int J Pharm. 2011 Aug 30;415(1-2):62-72. doi: 10.1016/j.ijpharm.2011.05.043. Epub 2011 Jun 12.
8
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.采用新型分级技术生产“空气动力学等效”药物和赋形剂吸入性粉末。
Eur J Pharm Biopharm. 2011 Feb;77(2):283-96. doi: 10.1016/j.ejpb.2010.11.021. Epub 2010 Dec 23.
9
Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose.轻度加工压力对吸入疗法干粉吸入剂配方性能的影响。1:布地奈德和乳糖。
Eur J Pharm Biopharm. 2011 May;78(1):97-106. doi: 10.1016/j.ejpb.2010.12.020. Epub 2010 Dec 21.
10
Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions.硫酸沙丁胺醇和乳糖的粘性混合物对动态条件下气溶胶化和去团聚行为的结构影响。
Eur J Pharm Sci. 2011 Feb 14;42(3):210-9. doi: 10.1016/j.ejps.2010.11.008. Epub 2010 Nov 26.